Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02577679
Other study ID # 201503116RINA
Secondary ID
Status Active, not recruiting
Phase N/A
First received September 23, 2015
Last updated October 14, 2015
Start date June 2015
Est. completion date November 2015

Study information

Verified date October 2015
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Ministry of Health and Welfare
Study type Observational

Clinical Trial Summary

The aim of this case control study is to explore the possible association between periodontal destruction and serum anti-CCP antibodies in RA patients and healthy subjects.


Description:

In patients with RA, the anti-CCP antibody titer seems positively correlated to their periodontal destruction and disease activity in comparison with healthy subjects.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 47
Est. completion date November 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 60 Years to 80 Years
Eligibility

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Serum level of anti-cyclic citrullinated peptide/protein antibody Lower then 7 Unit/milliliter: negative 7-10 Unit/milliliter: weak positive Higher then 10 Unit/milliliter: positive Base line Yes
Primary Periodontal pocket depth and clinical attachment level Lower then 4 millimeter: normal Higher then 4 millimeter: diseased/previously diseased Baseline No
Secondary Serum level of tumor necrotic factor alpha Recorded in picogram per milliliter Baseline Yes
Secondary Serum level of anti-mutated citrullinated vimentin Recorded in Unit per milliliter Baseline Yes
Secondary Serum level of interleukin 6 Recorded in picogram per milliliter Baseline Yes
Secondary Serum level of interleukin 17 Recorded in picogram per milliliter Baseline Yes